MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies

Brings biopharmaceutical industry closer to digitally-enabled manufacturing facility of the future

MAST^® Platform provides real-time process information; cuts process development time by half, improving efficiency and lowering costs

Burlington, MA, April 5, 2022 – MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today announced the acquisition of MAST^® (Modular Automated Sampling Technology) platform from Lonza. The MAST^® platform is an automated, aseptic bioreactor sampling system designed to advance bioprocessing capabilities for more efficient and cost-effective drug manufacturing. The MAST^® platform was developed in Bend, Oregon. The financial details of the deal were not disclosed. ...  Read more

DESSAU-ROSSLAU, Germany, March 1, 2022 /PRNewswire/ — IDT Biologika, a leading Contract Development and Manufacturing Organization (CDMO) specialized in vaccines, gene and immune therapy and oncolytic viruses based in Germany, and Exothera S.A. collaborate to develop a large-scale manufacturing process for viral vector-based vaccines. The feasibility study is focussing on Modified Vaccinia Ankara (MVA) virus as a first example for IDT’s broad range of vector technologies. ...  Read more

805 Douglas Legum Drive sells for $3.9 million and 6330 Howard Lane trades for $1.25 million ...  Read more

The Ellume COVID-19 Home Test is an over-the-counter, rapid self-test which detects SARS-CoV-2 antigen. The test is suitable for ages 2 years and above for over-the-counter home use in the U.S*. Clinically proven for use for people with and without symptoms, with accurate test results in 15 minutes. ...  Read more

HBVtech, located in Frederick, MD, is a biopharma startup developing a novel chronic Hepatitis B cure drug that only requires a single injection. HBVtech has established proof of three concepts for this new treatment strategy and drug and is preparing for IND (Investigational New Drug) studies. This new drug was selected as one of the Hepatitis B drug cure candidates by NIH. ...  Read more

Rural Maryland Council honored FITCI  for Outstanding Leadership and Public Service in Advocating Policy Solutions to Greatly Benefit Rural Communities. ...  Read more

Interim data from 27 patients, who had completed 3 months in the HBV002 study in chronic Hepatitis B (CHB) patients, demonstrated noted changes in surface antigen (HBsAg) levels, especially in the group receiving low-dose nivolumab with the heterologous boost (VTP-300). ...  Read more

December 2, 2021 ...  Read more

Rapid Prototyping & Manufacturing Technologies, LLC was established in a cozy basement in Harford County, MD. It was a scary, yet exciting time. ...  Read more